A detailed history of Mountain Pacific Investment Advisers Inc transactions in Amgen Inc stock. As of the latest transaction made, Mountain Pacific Investment Advisers Inc holds 6,324 shares of AMGN stock, worth $1.67 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
6,324
Previous 5,244 20.59%
Holding current value
$1.67 Million
Previous $1.64 Million 24.36%
% of portfolio
0.14%
Previous 0.12%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$309.38 - $337.38 $334,130 - $364,370
1,080 Added 20.59%
6,324 $2.04 Million
Q2 2024

Jul 10, 2024

SELL
$262.75 - $319.31 $42,040 - $51,089
-160 Reduced 2.96%
5,244 $1.64 Million
Q1 2024

Apr 11, 2024

SELL
$268.87 - $324.56 $16,132 - $19,473
-60 Reduced 1.1%
5,404 $1.54 Million
Q3 2023

Oct 20, 2023

BUY
$218.65 - $271.46 $3,061 - $3,800
14 Added 0.26%
5,464 $1.47 Million
Q2 2023

Jul 26, 2023

SELL
$214.27 - $253.37 $3,856 - $4,560
-18 Reduced 0.33%
5,450 $1.21 Million
Q1 2023

May 23, 2023

SELL
$225.79 - $275.2 $11,289 - $13,760
-50 Reduced 0.91%
5,468 $1.32 Million
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $4,489 - $5,063
-20 Reduced 0.36%
5,518 $1.24 Million
Q1 2022

Apr 19, 2022

SELL
$219.27 - $242.57 $4,166 - $4,608
-19 Reduced 0.34%
5,538 $1.34 Million
Q4 2021

Jan 19, 2022

SELL
$198.88 - $227.6 $74,580 - $85,350
-375 Reduced 6.32%
5,557 $1.25 Million
Q3 2021

Oct 25, 2021

SELL
$212.27 - $248.7 $15,707 - $18,403
-74 Reduced 1.23%
5,932 $1.26 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $93,432 - $103,656
-400 Reduced 6.24%
6,006 $1.46 Million
Q4 2020

Jan 21, 2021

BUY
$216.38 - $257.67 $21,638 - $25,767
100 Added 1.59%
6,406 $1.47 Million
Q3 2020

Oct 13, 2020

SELL
$234.65 - $260.95 $132,577 - $147,436
-565 Reduced 8.22%
6,306 $1.6 Million
Q2 2020

Jul 09, 2020

BUY
$197.81 - $242.74 $69,035 - $84,716
349 Added 5.35%
6,871 $1.62 Million
Q1 2020

Apr 08, 2020

BUY
$182.24 - $241.7 $519,566 - $689,086
2,851 Added 77.66%
6,522 $1.32 Million
Q2 2019

Jul 23, 2019

BUY
$166.7 - $195.41 $110,021 - $128,970
660 Added 21.92%
3,671 $676,000
Q1 2018

Apr 30, 2018

BUY
$169.43 - $198.0 $12,198 - $14,256
72 Added 2.45%
3,011 $513,000
Q4 2017

Jan 23, 2018

BUY
$168.79 - $188.59 $26,837 - $29,985
159 Added 5.72%
2,939 $511,000
Q3 2017

Oct 20, 2017

BUY
$167.29 - $191.0 $465,066 - $530,980
2,780
2,780 $518,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mountain Pacific Investment Advisers Inc Portfolio

Follow Mountain Pacific Investment Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Pacific Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Pacific Investment Advisers Inc with notifications on news.